However, IFN-α together with methyl-thiohydantoin-dl-Trp, an IDO inhibitor, decreased renal cancer cell growth, highlighting the role of IDO inhibitors as potential anticancer agents. The gene discussed is IDO1; the disease is renal carcinoma.